PROSTATE CANCER CLASSIFICATION
A method is provided for characterising and/or prognosing prostate cancer in a subject comprising determining the expression level of at least one of CREM, ERRFI1, SRSF5, PDK4, HJURP, PDRG1, TRPM3, PDE4D, F12, ADAMTS1, ADAMTS9, B3GNT5, CD38, CEBPD, CENPF, DKK1, EMP1, F3, IL1 R1, IL8, JUNB, KLF10, KL...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English Spanish |
Published |
13.10.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | A method is provided for characterising and/or prognosing prostate cancer in a subject comprising determining the expression level of at least one of CREM, ERRFI1, SRSF5, PDK4, HJURP, PDRG1, TRPM3, PDE4D, F12, ADAMTS1, ADAMTS9, B3GNT5, CD38, CEBPD, CENPF, DKK1, EMP1, F3, IL1 R1, IL8, JUNB, KLF10, KLF4, LDLR, LGALS3, LPAR1, MALAT1, MTUS1, MYBPC1, NFIL3, NR4A3, OAT, PI15, PTGS2, RHOBTB3, RIN2, RNFT2, SELE, SLC15A2, SOCS2, SOCS3, SSTR1, ST6GAL1, TSC22D1, XBP1 and ZFP36 in a sample from the subject. The method may be used to predict the likelihood of metastasis. Also disclosed are methods for diagnosing and selecting treatment for prostate cancer, together with corresponding methods of treatment. Systems, kits and computer programs for performing the methods are also provided.
Se proporciona un método para la caracterización y/o pronóstico de cáncer de próstata en un individuo, que consiste en: determinar el nivel de expresión de al menos uno de los siguientes CREM, ERRFI1, SRSF5, PDK4, HJURP, PDRG1, TRPM3, PDE4D, F12, ADAMTS1, ADAMTS9, B3GNT5, CD38, CEBPD, CENPF, DKK1, EMP1, F3, IL1 R1, IL8, JUNB, KLF10, KLF4, LDLR, LGALS3, LPAR1, MALAT1, MTUS1, MYBPC1, NFIL3, NR4A3, OAT, PI15, PTGS2, RHOBTB3, RIN2, RNFT2, SELE, SLC15A2, SOCS2, SOCS3, SSTR1, ST6GAL1, TSC22D1, XBP1 y ZFP36 en una muestra obtenida del individuo. El método puede utilizarse para predecir la probabilidad de metástasis. También se describen los métodos para el diagnóstico y selección del tratamiento para cáncer de próstata, junto con los métodos de tratamiento correspondientes. También se proporcionan sistemas, kits y programas de cómputo para realizar los métodos. |
---|---|
AbstractList | A method is provided for characterising and/or prognosing prostate cancer in a subject comprising determining the expression level of at least one of CREM, ERRFI1, SRSF5, PDK4, HJURP, PDRG1, TRPM3, PDE4D, F12, ADAMTS1, ADAMTS9, B3GNT5, CD38, CEBPD, CENPF, DKK1, EMP1, F3, IL1 R1, IL8, JUNB, KLF10, KLF4, LDLR, LGALS3, LPAR1, MALAT1, MTUS1, MYBPC1, NFIL3, NR4A3, OAT, PI15, PTGS2, RHOBTB3, RIN2, RNFT2, SELE, SLC15A2, SOCS2, SOCS3, SSTR1, ST6GAL1, TSC22D1, XBP1 and ZFP36 in a sample from the subject. The method may be used to predict the likelihood of metastasis. Also disclosed are methods for diagnosing and selecting treatment for prostate cancer, together with corresponding methods of treatment. Systems, kits and computer programs for performing the methods are also provided.
Se proporciona un método para la caracterización y/o pronóstico de cáncer de próstata en un individuo, que consiste en: determinar el nivel de expresión de al menos uno de los siguientes CREM, ERRFI1, SRSF5, PDK4, HJURP, PDRG1, TRPM3, PDE4D, F12, ADAMTS1, ADAMTS9, B3GNT5, CD38, CEBPD, CENPF, DKK1, EMP1, F3, IL1 R1, IL8, JUNB, KLF10, KLF4, LDLR, LGALS3, LPAR1, MALAT1, MTUS1, MYBPC1, NFIL3, NR4A3, OAT, PI15, PTGS2, RHOBTB3, RIN2, RNFT2, SELE, SLC15A2, SOCS2, SOCS3, SSTR1, ST6GAL1, TSC22D1, XBP1 y ZFP36 en una muestra obtenida del individuo. El método puede utilizarse para predecir la probabilidad de metástasis. También se describen los métodos para el diagnóstico y selección del tratamiento para cáncer de próstata, junto con los métodos de tratamiento correspondientes. También se proporcionan sistemas, kits y programas de cómputo para realizar los métodos. |
Author | Richard KENNEDY Laura HILL Andrena MCCAVIGAN Timothy DAVISON Steven WALKER Paul HARKIN |
Author_xml | – fullname: Laura HILL – fullname: Andrena MCCAVIGAN – fullname: Timothy DAVISON – fullname: Paul HARKIN – fullname: Steven WALKER – fullname: Richard KENNEDY |
BookMark | eNrjYmDJy89L5WSQCwjyDw5xDHFVcHb0c3YNUnD2cQwO9nTzdHYM8fT342FgTUvMKU7lhdLcDEpuriHOHrqpBfnxqcUFicmpeakl8b4RRgaGZgYG5sbGxo7GRCkCANtdI6k |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences Physics |
DocumentTitleAlternate | CLASIFICACION DE CANCER DE PROSTATA. |
ExternalDocumentID | MX2016007333A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_MX2016007333A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:54:28 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English Spanish |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_MX2016007333A3 |
Notes | Application Number: MX20160007333 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20161013&DB=EPODOC&CC=MX&NR=2016007333A |
ParticipantIDs | epo_espacenet_MX2016007333A |
PublicationCentury | 2000 |
PublicationDate | 20161013 |
PublicationDateYYYYMMDD | 2016-10-13 |
PublicationDate_xml | – month: 10 year: 2016 text: 20161013 day: 13 |
PublicationDecade | 2010 |
PublicationYear | 2016 |
RelatedCompanies | ALMAC DIAGNOSTICS LIMITED |
RelatedCompanies_xml | – name: ALMAC DIAGNOSTICS LIMITED |
Score | 2.9192145 |
Snippet | A method is provided for characterising and/or prognosing prostate cancer in a subject comprising determining the expression level of at least one of CREM,... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PHYSICS PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS TESTING VINEGAR WINE |
Title | PROSTATE CANCER CLASSIFICATION |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20161013&DB=EPODOC&locale=&CC=MX&NR=2016007333A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LSsNAcKhVqzeNilotQSS3YMLmeQiSbhKKmCbEKLmVJtlAEbSYiL_v7JJqTz3uzjL7gHnuPADuG8chaDVYKrN4UW3NdlWn1FzVRmZYMbKsLcb9kPHcmr0aT4VZDOB9kwsj6oT-iOKISFEV0nsn-PX634kViNjK9qFc4dTnY5R7gdJbx6i-oEqjBFMvTJMgoQqlXlwo80zARINC4u_BPurRNieH8G3K01LW2zIlOoGDFNF9dKcwYK0ER3TTek2CUdz_eEtwKEI0K1ww6smwPYNJmiUvuZ-HMuW9ZTKZPvvIFaM-K_gc7qIwpzMVt1z8XXARF1vHIxcwRMufXYJsOszWWcNr9DXG0nJKU6_10iaNa6Dg0eorGO9AdL0TOoZjPuJsWCc3MOy-vtktyteunIh3-QWoYHkY |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ7Uqq03RY1arY0x3IgQyutADF0gqOURRMONFLokxkQbwfj3nd1Q7anXnc3sI_nmsTsPgNvaNFX0GnSJ6qyotmxYklnKlmSgMKyouljqlL1DhpEevEwfcy3vwfs6F4bXCf3hxRERURXiveXyevX_iOXy2MrmrnzDoc97P7NdsfOO0XxBk0Z0Z7aXxG5MRELsMBejlNN4g0LV2YFdtLENBgfvdcbSUlabOsU_hL0E2X20R9CjjQBDsm69JsAg7H68BdjnIZoVThh0MGyOYZyk8XPmZN6EsN4y6YTMHZSKfpcVfAI3vpeRQMIli78DFmG-sT31FPro-dMzmGgmNRRasxp99XShm6WmLJXSUGtriopHXp7DaAuji63UaxgGWTgv5g_R0wgOGIWJZEW9hH779U2vUNe25Zjf0S-BWHwL |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PROSTATE+CANCER+CLASSIFICATION&rft.inventor=Laura+HILL&rft.inventor=Andrena+MCCAVIGAN&rft.inventor=Timothy+DAVISON&rft.inventor=Paul+HARKIN&rft.inventor=Steven+WALKER&rft.inventor=Richard+KENNEDY&rft.date=2016-10-13&rft.externalDBID=A&rft.externalDocID=MX2016007333A |